Companies / BOC Sciences / Etaracizumab
BOC Sciences

Etaracizumab | BOC Sciences

Etaracizumab is a humanized monoclonal IgG1 antibody that targets alpha-v beta-3 integrin. Alpha-v beta-3 integrin plays an important role in tumor angiogenesis. Etaracizumab has the potential for the treatment of cancers.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.